Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
7.18
+0.04 (0.56%)
At close: Jul 11, 2025, 2:57 PM CST
SHA:688238 Revenue
Obio Technology (Shanghai) Corp. had revenue of 52.85M CNY in the quarter ending March 31, 2025, a decrease of -11.29%. This brings the company's revenue in the last twelve months to 241.42M, up 3.35% year-over-year. In the year 2024, Obio Technology (Shanghai) Corp. had annual revenue of 248.15M with 21.16% growth.
Revenue (ttm)
241.42M
Revenue Growth
+3.35%
P/S Ratio
19.28
Revenue / Employee
348.88K
Employees
692
Market Cap
4.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 248.15M | 43.34M | 21.16% |
Dec 31, 2023 | 204.81M | -86.50M | -29.69% |
Dec 31, 2022 | 291.30M | 36.36M | 14.26% |
Dec 31, 2021 | 254.95M | 112.18M | 78.57% |
Dec 31, 2020 | 142.77M | 79.85M | 126.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |